DHR

NYSE Danaher Corporation

Sep 29, 2026 · 4:59 AM ET LAST TRADE Market Closed

$226.44 ↓ -0.89 (-0.39%) Trading Down from the previous close of $227.33

YTD change: -1.08%
vs 20-day SMA: +6.83%
vs 200-day SMA: +12.20%

Price ranges

Previous day

$222.10 $228.38

open $223.40 close $227.33

+$3.93 (+1.76%)

Today

$0.00 $0.00

$226.44

Past week

$214.28 $228.38

from $215.84 now $226.44

+$10.60 (+4.91%)

Past month

$199.09 $228.38

from $216.07 now $226.44

+$10.37 (+4.80%)

This year

$160.93 $242.80

from $228.92 now $226.44

-$2.48 (-1.08%)

Price & Performance

+43.44 (+23.62%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 32.2% away from all-time highs of $333.96
DHR is down 1% since the beginning of the year
DHR is up 22% over the past 12 months
DHR is up 5% over the past 1 month
1% of all DHR investors are betting against DHR
Number of investors short DHR has gone down 31% versus last month

DHR reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +22.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $1.94

Earnings momentum -1.4% Quarterly EPS growth

Quarterly change -1.4%

Valuation

P/E ratio 39.75

Enterprise value $182.4B

Beta 0.68

Balance sheet & scale

Income$4.0M

Revenue$25.1B

Cash$4.3B

Debt$27.9M

Income / Debt 0.14×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Computer and Electronic Product Manufacturing

Market cap $159.2B

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Competitor comparison

Ticker	Company	Price	Change
EMR	Emerson Electric Co.	$159.39	+0.73%
AME	AMETEK, Inc.	$251.67	+0.37%
SMNS.CAT	SIEMENS A G CDR CIBC REG S	$33.67	-0.09%
MKSI	MKS Inc.	$258.38	-0.94%
FTV	Fortive Corp.	$55.76	-0.59%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.